BridgeBio Pharma (NASDAQ:BBIO) reported its Q4 earnings results on Thursday, February 22, 2024 at 07:30 AM.

Here's what investors need to know about the announcement.

Earnings

BridgeBio Pharma missed estimated earnings by 5.49%, reporting an EPS of $-0.96 versus an estimate of $-0.91.

Revenue was down $125 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.27 which was followed by a 7.1% increase in the share price the next day.

Here's a look at BridgeBio Pharma's past performance:

** Listen to the earnings announcement yourself by clicking here. **

To track all earnings releases for BridgeBio Pharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.